Type 2 Diabetes Mellitus and Non-Metastatic Colorectal Cancer: A Retrospective Study on Survival and Toxicity Profiles.

Naglaa Said ElabdMahmoud Magdy AlabassyRanda Mohamed SeddikAmany A AmerReham Ahmed AbdelazizAhmed Sohaib

Published in: Asian Pacific journal of cancer prevention : APJCP (2024)

T2DM is considered a risk factor for poor survival among CRC patients. Treatment related toxicity is not affected by the presence or absence of diabetes, yet neuropathy needs further studies for diabetic patients receiving oxaliplatin.

Keyphrases

metastatic colorectal cancer
type diabetes
end stage renal disease
glycemic control
ejection fraction
newly diagnosed
oxidative stress
cardiovascular disease
chronic kidney disease
peritoneal dialysis
prognostic factors
metabolic syndrome
adipose tissue
wound healing